Prognostic Significance of Histologic Subtype in Stage I Non-Small Cell Lung Cancer

被引：0
|
作者：
Moon, Youngkyu [1 ]
Park, Jae Kil [1 ]
Sung, Sook Whan [1 ]
机构：
[1] Seoul St MaryS Hosp, Thorac & Cardiovasc Surg, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Prognosis; histologic component; Squamous cell carcinoma; Adenocarcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-015
引用
收藏
页码：S559 / S560
页数：2
相关论文
共 50 条
  • [21] The prognostic impact of tumor volume on stage I non-small cell lung cancer
    Su, Xiao-Dong
    Xie, Hao-Jun
    Liu, Qian-Wen
    Mo, Yun-Xian
    Long, Hao
    Rong, Tie-Hua
    [J]. LUNG CANCER, 2017, 104 : 91 - 97
  • [22] Analysis for prognostic factors of postoperative stage I non-small cell lung cancer
    Park, C
    Park, H
    Keum, D
    Kang, Y
    Han, S
    [J]. LUNG CANCER, 2005, 49 : S358 - S358
  • [23] Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer
    Marchetti, A
    Bertacca, G
    Buttitta, F
    Chella, A
    Quattrocolo, G
    Angeletti, CA
    Bevilacqua, G
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (08) : 2077 - 2081
  • [24] Prognostic significance of DAP kinase promoter hypermethylation in stage I non-small cell lung cancer patients.
    Zhou, Xiao
    Wen, Sijin
    Tang, Ximing
    Liu, Diane
    Khuri, Fadlo R.
    Hardy, Robert J.
    Lee, Eun Sul
    Tortolero-Luna, Guillermo
    Shen, Yu
    Mao, Li
    Lee, J. Jack
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [25] Prognostic Factors and the Significance of Treatment After Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer
    Shimada, Yoshihisa
    Saji, Hisashi
    Yoshida, Koichi
    Kakihana, Masatoshi
    Honda, Hidetoshi
    Nomura, Masaharu
    Usuda, Jitsuo
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    [J]. CHEST, 2013, 143 (06) : 1626 - 1634
  • [26] ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Nizzoli, R.
    Bartolotti, M.
    Gelsomino, F.
    Tiseo, M.
    Majori, M.
    Ferrari, L.
    De Filippo, M.
    Guazzi, A.
    Rindi, G.
    Ardizzoni, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [27] ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Nizzoli, R.
    Guazzi, A.
    Bartolotti, M.
    Gelsomino, F.
    Tiseo, M.
    Majori, M.
    Ferrari, L.
    De Filippo, M.
    Rindi, G.
    Ardizzoni, A.
    [J]. ACTA CYTOLOGICA, 2010, 54 (03) : 406 - 407
  • [28] ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Tiseo, M.
    Nizzoli, R.
    Guazzi, A.
    Bartolotti, M.
    Gelsomino, F.
    Majori, M.
    Ferrari, L.
    De Filippo, M.
    Silini, E. M.
    Ardizzoni, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S47 - S47
  • [29] Prognostic Significance of Telomerase Polymorphism in Non-Small Cell Lung Cancer
    Catarino, Raquel
    Araujo, Antonio
    Coelho, Ana
    Gomes, Monica
    Nogueira, Augusto
    Lopes, Carlos
    Medeiros, Rui M.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (14) : 3706 - 3712
  • [30] Osteopontin expression and prognostic significance in non-small cell lung cancer
    Donati, V
    Boldrini, L
    Dell'Omodarme, M
    Prati, MC
    Faviana, P
    Camacci, T
    Lucchi, M
    Mussi, A
    Santoro, M
    Basolo, F
    Fontanini, G
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6459 - 6465
12345